GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general med...
Bipolar Study in Adults at Least 18 Years of Age
- First Posted Date
- 2003-09-05
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1200
- Registration Number
- NCT00067938
- Locations
- πΊπΈ
GSK Investigational Site, West Allis, Wisconsin, United States
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics
- Conditions
- First Posted Date
- 2003-09-05
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 190
- Registration Number
- NCT00067951
- Locations
- π³πΏ
GSK Investigational Site, Wellington, New Zealand
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
- Conditions
- First Posted Date
- 2003-08-25
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 702
- Registration Number
- NCT00067561
- Locations
- π¦πΊ
GSK Investigational Site, Nedlands, Western Australia, Australia
Depression Study In Elderly Patients
- Conditions
- First Posted Date
- 2003-08-21
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 560
- Registration Number
- NCT00067444
- Locations
- πΊπΈ
GSK Investigational Site, Salt Lake City, Utah, United States
Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
- Conditions
- First Posted Date
- 2003-08-21
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 700
- Registration Number
- NCT00067457
- Locations
- π¦πΊ
GSK Investigational Site, Nedlands, Western Australia, Australia
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-07-18
- Last Posted Date
- 2019-06-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 399
- Registration Number
- NCT00065182
- Locations
- π΅π±
GSK Investigational Site, Szczecin Zdunowo 20, Poland
Lethargic Depression Study
- Conditions
- First Posted Date
- 2003-07-10
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 268
- Registration Number
- NCT00064467
- Locations
- πΊπΈ
GSK Investigational Site, San Antonio, Texas, United States
Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab
- Conditions
- First Posted Date
- 2003-06-19
- Last Posted Date
- 2007-09-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 12
- Registration Number
- NCT00062894
- Locations
- πΊπΈ
University of Michigan Medical Center, Ann Arbor, Michigan, United States
πΊπΈUniversity of Nebraska Medical Center, Omaha, Nebraska, United States
πΊπΈDuke University Medical Center, Durham, North Carolina, United States
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
- Conditions
- First Posted Date
- 2003-06-17
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 50
- Registration Number
- NCT00062790
- Locations
- πΊπΈ
GSK Investigational Site, Richmond, Virginia, United States
GW572016 For Treatment Of Refractory Metastatic Breast Cancer
- Conditions
- First Posted Date
- 2003-06-12
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 200
- Registration Number
- NCT00062686
- Locations
- π¬π§
GSK Investigational Site, Manchester, United Kingdom